Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2113873
Abstract: ABSTRACT Helicase-primase is an interesting target for small-molecule therapy of herpes simplex virus (HSV) infections. With amenamevir already approved for varicella-zoster virus and with pritelivir’s granted breakthrough therapy designation for the treatment of acyclovir-resistant HSV…
read more here.
Keywords:
simplex virus;
drug candidate;
phaeno therapeutics;
helicase primase ... See more keywords